Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FAKE TWEET. Please keep it real.
GM SGBY! Still long and holding. Personally I am not worried about the financials. We all know this is a long term Gem! I just wonder how many people will be kicking themselves this time next year because they were too impatient. GLTYA. All IMO.
Just throwing this out there.... Is it possible that TD stopped letting folks buy because they don't have shares to sell and they know news is coming? I could be totally wrong. Guess I will still have to wait and see how this plays out. Still holding what was able to get. GLTA
Looks like .0001's will be available soon enough.
$hort Squeeze Play?
Thanks for all the responses. I do appreciate it. I guess I will have to wait and see what Monday brings.
Newbie question. Tried to buy at .0003 with TD and it gives me an error saying this can only purchased in paper certificate form. I bought some the other day with no problem. What does this mean?
MIAMI, FL / ACCESSWIRE / February 14 , 2017 / Biotech Products Services and Research, Inc. (OTC PINK: BPSR) ("Company") today announced that its wholly-owned subsidiary, Anu Life Sciences Inc. ("Anu"), has recently received satisfactory validation for its first production batch of amniotic allograft biological product ("New Amnio Product") and has commenced shipping the New Amnio Product to customers. The New Amnio Product is being sold through Anu's designated distributor and affiliate, General Surgical Inc. ("General Surgical"), under the name "Regen Anu Rheo." The Company expects to increase production of the New Amnio Product in quantities to ensure there is satisfactory inventory to meet anticipated demand.
The commencement of Regen Anu Rheo shipments follows the Company's January 12, 2017 announcement that it had successfully completed trial production runs of Regen Anu Rheo and was only awaiting satisfactory confirmation of test results before commencing distribution.
Regen Anu Rheo is the first of several amniotic-based biologics products that the Company intends to develop, manufacture and supply to the health care industry, specifically health care providers including doctors, clinics and hospitals ("Providers").
Mr. Albert Mitrani, the Company's Chief Executive Officer commented, "We are excited to have successfully developed and produced the first of many of our planned newly developed innovative biologic tissue products. We believe that our proprietary protocols for the processing of amniotic tissue are superior to those processes used in existing amniotic tissue derived products produced by our competitors."
About Biotech Products Services and Research, Inc.
Biotech Products Services and Research, Inc. and its subsidiaries ("Company") is a supplier of products and services used in the growing health care field of regenerative medicine.
The Company's strategy is to be a leading supplier of newly designed advanced biologically processed cellular and tissue based products and services used in the growing health care field of regenerative medicine.
CAUTIONARY COMMENT REGARDING FORWARD-LOOKING STATEMENTS
The foregoing contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. We intend for these forward-looking statements to be covered by the safe harbor provisions of the federal securities laws relating to forward-looking statements. This release contains forward-looking statements that reflect Biotech Products Services & Research, Inc., and its subsidiaries, plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "goal" and similar expressions are used to identify forward-looking statements, representing management's current judgment and expectations about possible future events.
Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, achievements or financial position to be materially different from any expressed or implied by these forward-looking statements. Important factors that could cause actual results to differ materially from the forward-looking statements are set forth in our Form 10-K and other filings with the SEC. Other information can be obtained at www.bpsrhealth.com. The contents of the Company's website are not incorporated by reference in this Press Release.
CONTACT:
Biotech Products Services and Research, Inc.
4045 Sheridan Ave., Suite 239
Miami Beach, FL 33140
Website: http://www.bpsrhealth.com
Phone: (888) 963-7881
Email: info@bpsrhealth.com
SOURCE: Biotech Products Services and Research Inc.
http://finance.yahoo.com/news/biotech-products-services-research-inc-210000104.html
GM SGBY! Still long an $trong. Patience pays IMHO.
Agree Mary. This is going bounce. .03+ today for sure. But no way this girl is selling for that. I am waiting like you for big $. GLTA
Looks like the typical shake out. Hope those that sold still have some left.
Buckle up longs! $$$$
GM SGBY! Still long and $trong. Looking forward to all the updates in 2017. Still holding at .0045 :)
Agreed GreenScarab :) Still Long and $trong and will continue to be. Looking forward to 2017. Patience pays and SGBY is a great hold and buy IMHO
My Think or Swim shows bid 10k@.0204 and ask 491.8k@.0227.
Looking forward to seeing SGBY's 2017 plan. Still long and $trong!
Awesome News! Every SGBY update gets better and better. Still long and $trong!!!!
Will jump in at .0001 maybe .0002 if this bounces. Looks like it could be a fun ride. IMO
Check my history. Anyone can see you are wrong. No pump. Just long holders here and it looks like we shook out our resident flipper and now this has no where to go but up.
No pump here. Just shares locked up by shareholders.
SS LOCKED! Company CAN NOT Dillute!!!! Buckle Up!
L2 is thin and has been. We may have finally shaken the last of the weak hands out. Hold tight and ride this up!
Been in for almost a year. When this ran last time it was a $ maker!
What made this move? This is super thin. Wow!
L2 lining up nicely. Could be wrong but looks like MM's are ready to let this run some. IMO.
L2 lining up nicely. Could be wrong but looks like MM's are ready to let this run some. IMO.
SGBY's lab "Kenevir Research is the only lab south of Eugene certified to test marijuana". Someone else may have already posted this, but I missed it and thought it was important to note. Their location puts them in high demand. IMHO.
https://kobi5.com/news/local-news/world-of-weed-marijuana-testing-labs-40032/
Awesome News! Cashflow positive and climbing! Enjoy the ride :)
Awesome News! Cashflow positive and climbing! Enjoy the ride :)
We are still here and still very positive. Seems longs are not posting as much because there is no need to "hype" this up. SGBY can stand on its own merit and will run when the time is right. All IMHO. GLTYA!
Not sure this is relevant but I have my google set for SGBY alerts and this aticle just came in.
http://www.kentuckypostnews.com/2016/11/15/shorts-on-watch-signal-bay-incorporated-otcmktssgby-shorted-shares-increased-by-409-67/
Great point Rocketstocks.
Great News! CEO is on the ball for sure. Keeps delivering as planned and throws in a few bonuses to boot. 2017 is going to be a great year for this company and its investors IMHO. All the more reason to hold long and load when I can. GLTA!!!!
Agree with you longs. This happens every once in while. People get impatient expecting big gains everyday. Then the shake out occurs and people get scared and sell. And then we see new higher highs and people post that they are kicking themselves and regret that they sold. Not telling anyone what to do. This is my opinion based on being in this stock for while now. I am holding tight. This next run is gonna be a good one. IMO.
Great Post Magnum! Glad to see you back on the board sharing great input and DD. Thank you!
A no vote would not change anything for SGBY currently. Their current labs would continue to profit. A yes vote just opens more opportunities faster.
Great Post. All should read this. Quote from fellow board member.
QUOTE:
___________________________________________________________________
Rocketstocks Member Level Tuesday, 11/01/16 04:19:55 PM
Re: Rocketstocks post# 16108
Post # of 17888
Its important for people to understand that, unlike many MJ investments, they dont depend on the Cali vote passing to start making money in the state and when it does pass, they dont have to wait until 2018 for legalization to take effect. They are already making $$$ with the 1300 paying customers they added this week in the largest state... along with 95% of the smaller, but growing Oregon market.
The growth trend will be strong.
PS: Help keep this board full of DD so we can edumucate the masses on the unique potential here.
__________________________________________________________________
End Quote.
Great Point.
These marijuana investors are ready to spend millions if California passes Prop 64
http://www.mercurynews.com/2016/11/08/these-marijuana-investors-are-ready-to-spend-millions-if-california-passes-prop-64/